NEW YORK (GenomeWeb News) – The Biomedical Diagnostics Institute in Dublin, Ireland, said today that it has purchased one of Biacore’s label-free protein interaction systems for its diagnostics research programs.

BDI said it will use Biacore’s A100 system to help develop diagnostics for cardiac conditions, cancer, blood coagulation and monitoring, and for mastitis in cattle.

The institute used funds from Science Foundation Ireland to buy the system, and said it is the first academic research institute in Europe to install one.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.